Back to Results
First PageMeta Content
Selective serotonin reuptake inhibitors / Organofluorides / Organochlorides / Piperazines / Atypical antipsychotics / Aripiprazole / Antipsychotic / Ondansetron / Extrapyramidal symptoms / Chemistry / Organic chemistry / Medicine


21684 Otsuka Abilify Maintena 8.5 x 11 PI AA3:Layout 1
Add to Reading List

Document Date: 2013-11-20 12:05:04


Open Document

File Size: 1.000,21 KB

Share Result on Facebook

Company

Human Experience / Otsuka America Pharmaceutical Inc. / /

Currency

pence / /

Event

Product Issues / FDA Phase / Product Recall / /

Facility

QRS complex / Poison Control Center / /

IndustryTerm

antipsychotic drug products / machinery / excess product / needle protection device / food / healthcare professionals / healthcare professional / serotonin reuptake site / injection site / rubber stopper / safety device / needle safety device / chemical structure / /

MedicalCondition

polyuria / photophobia / anaphylactic reaction / Neuroleptic Malignant Syndrome A / acidosis / Seizures / esophagitis / coma / convulsion / Extrapyramidal Disorder / anaphylaxis / cerebrovascular disease / depressed level of consciousness / hyponatremia / Injury / diabetic ketoacidosis / bradykinesia / disorder / bradycardia / Poisoning / Neuroleptic Malignant Syndrome / hepatitis / gastroesophageal reflux disease / muscle rigidity / hypoglycemia / Nutrition Disorders / aspiration pneumonia / pneumonia / laryngospasm / schizophrenia / chronic treatment / Dysphagia / Carcinogenesis / hyperglycemia / undescended testes / Neutropenia / stroke / dyslipidemia / mania / diabetes / nasal congestion / Hyperglycemia/Diabetes Mellitus Hyperglycemia / fever / lethargy / seizure / Orthostatic Hypotension / Vomiting / Leukopenia/Neutropenia / Tardive Dyskinesia A / established tardive dyskinesia / dyskinesias / supraventricular tachycardia / atrial fibrillation / hypotonia / infection / Dystonia / dizziness / hypokalemia / rash / Tardive Dyskinesia / acute renal failure / pruritus/urticaria / status epilepticus / Chronic antipsychotic treatment / loss of consciousness / hyperglycemia/diabetes mellitus / muscular weakness / allergic reaction / myoclonus / chest pain / catatonia / urinary retention / Leukopenia / Muscle Spasms / alopecia / Known hypersensitivity / transient ischemic attack / Tremor / angina pectoris / atrioventricular block / obesity / tachycardia / both serious medical illness / neurodermatitis / hypersensitivity / myoglobinuria / Restlessness / heat stroke / hypokinesia / Constipation / confusional state / pruritus / systemic infection / Agranulocytosis / atrial flutter / gynecomastia / hypotension / extrasystoles / Insomnia / presyncope / Orthostasis / hypertension / Nervous System Disorders / erectile dysfunction / chronic illness / cardiac dysrhythmia / hernia / rhabdomyolysis / myocardial infarction / Toothache / Diabetes Mellitus / heart failure / urticaria / angioedema / delirium / seborrheic dermatitis / hyperosmolar coma / spasm / Cough / withdrawal symptoms / drug eruption / diplopia / myocardial ischemia / syndrome / bipolar disorder / akathisia / Dehydration / /

MedicalTreatment

massage / drug therapy / /

Organization

Poison Control Center / DOSAGE AND ADMINISTRATION / FDA / /

/

Position

Prime Minister / General / Investigator / /

Product

CYP3A4 / itraconazole / Escitalopram / MAINTENA suspension / erythromycin / fluoxetine / ABILIFY / Venlafaxine / Carbamazepine / MAINTENA injections / MAINTENA injection / omeprazole / mannitol / Procedures After Injection / Sterile Water for Injection / recommended volume / Ketoconazole / Concomitant Medication / MAINTENA Reconstituted Suspension / aripiprazole / for / /

Technology

alpha / Pharmacokinetics / Pharmacodynamics / /

URL

www.fda.gov/medwatch / /

SocialTag